| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 5.118 | 7.037 | 13.541 | 19.620 | 32.685 | 55.838 | 65.599 |
| Total Income - EUR | - | - | - | 5.118 | 7.037 | 13.541 | 19.620 | 32.685 | 55.838 | 65.599 |
| Total Expenses - EUR | - | - | - | 4.491 | 2.948 | 3.049 | 4.969 | 7.923 | 16.588 | 20.841 |
| Gross Profit/Loss - EUR | - | - | - | 627 | 4.089 | 10.492 | 14.650 | 24.762 | 39.251 | 44.759 |
| Net Profit/Loss - EUR | - | - | - | 474 | 3.877 | 10.109 | 14.074 | 23.801 | 38.703 | 42.830 |
| Employees | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Ticuşan Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 506 | 310 | 122 | 961 | 643 | 1.464 | 1.590 |
| Current Assets | - | - | - | 5.091 | 5.726 | 10.663 | 14.044 | 24.417 | 38.994 | 44.156 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 273 | 39 | 1.148 | 820 | 17.331 | 23.905 | 0 |
| Cash | - | - | - | 4.817 | 5.688 | 9.515 | 13.225 | 7.086 | 15.089 | 44.156 |
| Shareholders Funds | - | - | - | 517 | 4.384 | 10.167 | 14.122 | 23.849 | 38.752 | 42.878 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 5.080 | 1.652 | 617 | 883 | 1.210 | 1.944 | 3.097 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ticuşan Medical S.r.l.